U.S. scientists say they have achieved a one-step somatic cell nuclear transfer procedure using a differentiated cell as a nuclear donor.
The University of Connecticut researchers say their study demonstrates fully differentiated granulocytes yield cloned mice with greater efficiency than undifferentiated blood stem cells.
Somatic cell nuclear transfer -- SCNT -- is the procedure by which cloned animals are typically produced and involves the injection of a nucleus from a donor cell into an egg whose nucleus has been removed. Previous studies reported cloned mice could only be generated with differentiated cells as nuclear donors using a two-step procedure, in which the early embryos generated by SCNT are first used to generate embryonic stem cells that are subsequently injected into another recipient embryo.
Other studies also reported the cloning efficiency for embryonic stem cells is much higher than for other kinds of cells.
But Xiangzhong Yang and colleagues injected nuclei from blood cells at different stages of differentiation into donor eggs and report the nuclei of granulocytes allow for more efficient production of cloned embryos than blood stem cells.
They say two live pups were born using that procedure.
The experiment appears in the journal Nature Genetics.
Copyright 2006 by United Press International
Related stories:
Stem cell research puts interstate rivalry on hold
Victoria and New South Wales have put aside their competitive interstate rivalry to collaborate on a stem cell research project, as announced by Innovation Minister Gavin Jennings and NSW Minister for Science and Medical Research, Verity Firth, today.
New stem cell tools to aid drug development
SCIENTISTS have designed, developed and tested new molecular tools for stem cell research to direct the formation of certain tissue types for use in drug development programmes.
Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body
Magnetic resonance imaging (MRI) isn't just for capturing detailed images of the body's anatomy. Thanks to novel imaging reagents and technology developed by Carnegie Mellon University scientist Eric Ahrens, MRI can be used to visualize — with "exquisite" specificity — cell populations of interest in the living body. The ability to non-invasively locate and track cells, such as immune cells, will greatly aid the study and treatment of cancer, inflammation, and autoimmune diseases, as well as provide a tool for advancing clinical translation of the emerging field of cellular regenerative medicine, by tracking stem cells for example.
Study shows how daughter is different from mother
The mother-daughter relationship can be difficult to understand. Why are the two so different? Now a Northwestern University study shows how this happens. In yeast cells, that is.
Neurons created from skin cells of elderly ALS patients
Less than 27 months after announcing that he had institutional permission to attempt the creation of patient and disease-specific stem cell lines, Harvard Stem Cell Institute (HSCI) Principal Faculty member Kevin Eggan today proclaimed the effort a success - though politically imposed restrictions and scientific advances prompted him to use a different technique than originally planned.
Stem cell research from an ethical point of view
Stem cell research and the potential use of human embryonic stem cells in clinical therapy is a controversial issue which splits both scientific and public opinion. The current conflict over embryonic stem cells throughout the world deals particularly with the ethical implications of this promising, but delicate subject and the scientific manipulation of human life in its early stages of development. It is a symbolic struggle over the whole future of developmental biology – over how we will proceed with a wide range of research on human development. Alternative methods for gaining embryonic stem cells such as the Altered Nuclear Transfer (ANT) method developed by William B. Hurlbut, M.D., a member of The President's Council on Bioethics in Washington, D.C., are considered important steps torward embryonic stem cell research.
Public funding impacts progress of human embryonic stem cell research
Bolstered by supportive policies and public research dollars, the United Kingdom, Israel, China, Singapore and Australia are producing unusually large shares of human embryonic stem cell research, according to a report from the Georgia Institute of Technology in the June 2008 issue
Cell Stem Cell. Aaron Levine, assistant professor of public policy and author of the book Cloning: A Beginner's Guide, studied how countries output of research papers related to human embryonic stem cell research compared to their output in less contentious fields. He found that even though the United States still puts out far more research in this field than any other single country, when one compares the amount of research in human embryonic stem cells to other forms of research in molecular biology and genetics, the U.S. lags behind.
Policy environments may shape international progress of human embryonic stem cell research
Biomedical research may be substantially hampered by drawn out debates, conflicting legislation and restrictive policies. A new analysis, published by Cell Press in the June issue of
Cell Stem Cell, investigates the influence of policy environments on the progression of research related to human embryonic stem cells (hESC) and offers new insight into the international development of this often ethically controversial field.